Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.

Jasmine McCabe-Gossett began noticing mild neuropathy in her hands and feet. It quickly progressed to “one of the most ...

CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for ...

Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis (MG) and initial results from Period 1 of a mid-stage study of the ...

Chronic kidney disease (CKD) is defined as a progressive loss of renal function that lasts for more than 3 months, and is classified according to the degree of kidney damage – measured by the ...

The pivotal Phase III study in myasthenia gravis met its primary endpoint with meaningful improvements in MG-ADL across both higher and lower dose arms.

and chronic inflammatory demyelinating polyneuropathy (CIDP). Citing topline data, New York-based Immunovant (NASDAQ:IMVT) said its Phase 3 MG trial for the FcRn inhibitor met its primary endpoint in ...

Millions across the Midwest are bracing for a severe weather outbreak today, with the greatest risks for strong tornadoes, damaging winds, and large hail in Illinois and Indiana. Cities like Chicago, ...

Following screening, participants with moderate to severe MG were randomized into Period 1 where they received high dose batoclimab (680mg weekly) or lower dose batoclimab (340mg weekly ...

Detailed price information for Roivant Sciences Ltd (ROIV-Q) from The Globe and Mail including charting and trades.

Following screening, participants with moderate to severe MG were randomized into ... from Period 1 baseline in adjusted Inflammatory Neuropathy Cause and Treatment (aINCAT) disability score ...